133 related articles for article (PubMed ID: 25317032)
21. Experimental study on the protective effects of edaravone against ischemic spinal cord injury.
Suzuki K; Kazui T; Terada H; Umemura K; Ikeda Y; Bashar AH; Yamashita K; Washiyama N; Suzuki T; Ohkura K; Yasuike J
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1586-92. PubMed ID: 16308003
[TBL] [Abstract][Full Text] [Related]
22. [A comparative study on the protection effect of nerve growth factor and edaravone pretreatment against cerebral ischemia/reperfusion injury].
Fu JQ; Wang DF; Liu H
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):226-9. PubMed ID: 20398467
[TBL] [Abstract][Full Text] [Related]
23. Edaravone prevents lung injury induced by hepatic ischemia-reperfusion.
Uchiyama M; Tojo K; Yazawa T; Ota S; Goto T; Kurahashi K
J Surg Res; 2015 Apr; 194(2):551-557. PubMed ID: 25481526
[TBL] [Abstract][Full Text] [Related]
24. Involvement of calpain in myonephropathic metabolic syndrome (MNMS).
Tsuji Y; Kambayashi J; Shiba E; Sakon M; Kawasaki T; Mori T
Eur J Vasc Surg; 1994 Jul; 8(4):482-8. PubMed ID: 8088401
[TBL] [Abstract][Full Text] [Related]
25. Edaravone attenuates ischemia-reperfusion injury by inhibiting oxidative stress in a canine lung transplantation model.
Xu JZ; Shen BZ; Li Y; Zhang T; Xu WH; Liu XW; Lu HG
Chin Med J (Engl); 2008 Aug; 121(16):1583-7. PubMed ID: 18982873
[TBL] [Abstract][Full Text] [Related]
26. [An experimental study of myonephropathic metabolic syndrome (MNMS)].
Onuki Y; Adachi S; Ando M; Takeuchi S; Nakajima N; Okui K
Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):197-207. PubMed ID: 1552892
[TBL] [Abstract][Full Text] [Related]
27. Effect of edaravone on ischemia/reperfusion injury in rat urinary bladder--changes in smooth muscle cell phenotype and contractile function.
Matsumoto S; Hanai T; Shimizu N; Sugimoto K; Uemura H
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S46-9. PubMed ID: 20094953
[TBL] [Abstract][Full Text] [Related]
28. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of edaravone on systemic inflammation and local damage in skeletal muscles following long-term ischemia to murine hind limb.
Yokoyama H; Tsujii M; Iino T; Nakamura T; Sudo A
J Orthop Surg (Hong Kong); 2019; 27(3):2309499019874470. PubMed ID: 31549573
[TBL] [Abstract][Full Text] [Related]
30. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
31. The novel antioxidant edaravone: from bench to bedside.
Watanabe T; Tahara M; Todo S
Cardiovasc Ther; 2008; 26(2):101-14. PubMed ID: 18485133
[TBL] [Abstract][Full Text] [Related]
32. Effects of Edaravone on Nitric Oxide, Hydroxyl Radicals and Neuronal Nitric Oxide Synthase During Cerebral Ischemia and Reperfusion in Mice.
Kawasaki H; Ito Y; Kitabayashi C; Tanaka A; Nishioka R; Yamazato M; Ishizawa K; Nagai T; Hirayama M; Takahashi K; Yamamoto T; Araki N
J Stroke Cerebrovasc Dis; 2020 Mar; 29(3):104531. PubMed ID: 31882337
[TBL] [Abstract][Full Text] [Related]
33. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat.
Yagi H; Horinaka S; Matsuoka H
J Cardiovasc Pharmacol; 2005 Jul; 46(1):46-51. PubMed ID: 15965354
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of edaravone against renal ischemia/reperfusion injury and compared with ischemic postconditioning in rats.
Li Y; Xia AZ; Xing SH
Yao Xue Xue Bao; 2010 Jul; 45(7):840-8. PubMed ID: 20931780
[TBL] [Abstract][Full Text] [Related]
35. Cardioprotective effect of edaravone against ischaemia-reperfusion injury in the rabbit heart before, during and after reperfusion treatment.
Fukuda A; Okubo S; Tanabe Y; Hoshiba Y; Shiobara H; Harafuji K; Kobori Y; Fujinawa M; Okubo T; Yamashina A
J Int Med Res; 2006; 34(5):475-84. PubMed ID: 17133776
[TBL] [Abstract][Full Text] [Related]
36. UPEI-300, a conjugate of lipoic acid and edaravone, mediates neuroprotection in ischemia/reperfusion.
Connell BJ; Saleh MC; Kucukkaya I; Abd-El-Aziz AS; Khan BV; Saleh TM
Neurosci Lett; 2014 Feb; 561():151-5. PubMed ID: 24394910
[TBL] [Abstract][Full Text] [Related]
37. Edaravone: a new hope for deadly amyotrophic lateral sclerosis.
Bhandari R; Kuhad A; Kuhad A
Drugs Today (Barc); 2018 Jun; 54(6):349-360. PubMed ID: 29998226
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats.
Hiranuma S; Ito K; Noda Y; Ozasa H; Koike Y; Horikawa S
J Gastroenterol Hepatol; 2007 Dec; 22(12):2167-72. PubMed ID: 18031376
[TBL] [Abstract][Full Text] [Related]
39. Antioxidant effect of MCI-186, a new Free-Radical scavenger, on ischemia-reperfusion injury in a rat hindlimb amputation model.
Irie H; Kato T; Ikebe K; Tsuchida T; Oniki Y; Takagi K
J Surg Res; 2004 Aug; 120(2):312-9. PubMed ID: 15234228
[TBL] [Abstract][Full Text] [Related]
40. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
